Poractant alfa clinical trials
Also written Curosurf.
How each study uses poractant alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the poractant alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 18 Nov 1999 · CUROSURF · BLA 020744 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 17
Chiesi Farmaceutici S.p.A. (3) · Dr. Sami Ulus Children's Hospital (2) · University of Michigan (2) · Jean Michel Hascoet (1) · University of Missouri-Columbia (1) · Zekai Tahir Burak Women's Health Research and Education Hospital (1) · University of Cologne (1) · Hospital Clinic of Barcelona (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test poractant alfa.
- Feb 2027Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress SyndromePhase 4 · Uludag University
Studies
Open first, then newest update. How each study uses poractant alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 MinutesRecruitingPhase 4Medical University of GrazNCT07261787Written as Poractant alfa (Curosurf®) - 1-minute administrationHow we know
- Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress SyndromeRecruitingPhase 4Uludag UniversityNCT07350018Written as Poractant alfaHow we know
- Prophylactic Minimally Invasive Surfactant EvaluationRecruitingPhase 4Endeavor HealthNCT06007547Written as Poractant AlfaHow we know
- Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.Not yet recruitingPhase 3Hospital Clinic of BarcelonaNCT04862377Written as Poractant Alfa Intratracheal Suspension [Curosurf]How we know
- Medium vs Low Oxygen Threshold for the Surfactant AdministrationNot yet recruitingPhase 4Virgilio Paolo CarnielliNCT04199364Written as Poractant Alfa 80 mg/mL Intratracheal SuspensionHow we know
- Cold Heart Study: A Randomized Pilot Trial of Surfactant TherapyTerminatedPhase 1University of MichiganNCT04181255Written as CurosurfHow we know
- Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)TerminatedPhase 2Chiesi Farmaceutici S.p.A.NCT04502433Written as CUROSURF® (poractant alfa)How we know
- Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary DysplasiaCompletedPhase 4Jean Michel HascoetNCT01039285Written as CurosurfHow we know
- A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)TerminatedPhase 2Chiesi Farmaceutici S.p.A.NCT03235986Written as nCPAP (nasal Continuous Positive Airway Pressure) + Nebulised Curosurf® (Part I)How we know
- Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF TrialStatus unknownPhase 2VENTO GIOVANNINCT04825197Written as Poractant Alfa Intratracheal Suspension [Curosurf]How we know
- Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of AgeTerminatedPhase 3Azienda Ospedaliera Universitaria Integrata VeronaNCT03959384Written as Curosurf 80Mg/Ml Intratracheal SuspensionHow we know
- Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownPhase 2Dr Christophe LENCLUDNCT04384731Written as poractant alfaHow we know
- Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap StudyCompletedPhase 4Chiesi Farmaceutici S.p.A.NCT00501982Written as Poractant alfa (Curosurf®)How we know
- Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress SyndromeCompletedNot applicableUniversity of Missouri-ColumbiaNCT02834624Written as Poractant alfaHow we know
- Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration SyndromeCompletedPhase 4Zekai Tahir Burak Women's Health Research and Education HospitalNCT02041546Written as Lung lavage with surfactantHow we know
- Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress SyndromeWithdrawnNot applicableUniversity of MichiganNCT01537354Written as Curosurf®How we know
- Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary HemorrhageCompletedNot applicableDr. Sami Ulus Children's HospitalNCT01860014Written as Poractant alfaHow we know
- Perfusion Index Variability in Respiratory Distress SyndromeCompletedNot applicableDr. Sami Ulus Children's HospitalNCT01852461Written as Poractant alfaHow we know
- Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 WeeksCompletedNot applicableUniversity of CologneNCT00751959Written as CurosurfHow we know
- Curosurf and Survanta Treatment(CAST)of RDS in Very Premature InfantsTerminatedPhase 4Alan FujiiNCT00767039Written as Curosurf (poractant)How we know
Given beside what is tested · 2 — poractant alfa is usual care or a partner of the new treatment
- Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.Status unknownPhase 4Hospital Central "Dr. Ignacio Morones Prieto"NCT03521063Written as Poractant AlfaHow we know
- Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDSCompletedNot applicableCatholic University of the Sacred HeartNCT02482766Written as Poractant alfa, 200 mg/kgHow we know
As the comparator · 1 — what is tested is compared with poractant alfa
Codes
What other systems call poractant alfa · ClinicalTrials.gg INT003561
- MeSH (NLM) C068291poractant alfaConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) KE3U2023NPPORACTANT ALFAConfirmed FDA, NLM, Wikidata
- RxNorm 236381Confirmed FDA, Wikidata
- Wikidata Q15708403poractant alfaConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81353Poractant AlfaConfirmed FDA, Wikidata
- DrugBank DB09113One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C068291 | poractant alfa | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | KE3U2023NP | PORACTANT ALFA | Confirmed FDA, NLM, Wikidata |
| RxNorm | 236381 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15708403 | poractant alfa | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81353 | Poractant Alfa | Confirmed FDA, Wikidata |
| DrugBank | DB09113 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.